We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$617M
AUM Growth
-$413M
Cap. Flow
-$455M
Cap. Flow %
-73.77%
Top 10 Hldgs %
54.35%
Holding
5,864
New
1,647
Increased
1,144
Reduced
1,785
Closed
1,178

Sector Composition

Rank Sector Weight
1 Financials 1.97%
2 Technology 1.44%
3 Real Estate 1.39%
4 Energy 1.34%
5 Industrials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB
1851
DELISTED
CHUBB CORPORATION
CB
$13K ﹤0.01%
100
-100
-50% -$12.9K
GPM
1852
DELISTED
Guggenheim Enhanced Equity Income Fund
GPM
$13K ﹤0.01%
+1,706
New +$13.1K
ACIC icon
1853
American Coastal Insurance
ACIC
$493M
$12K ﹤0.01%
+700
New +$12.1K
ANY icon
1854
Sphere 3D
ANY
$16M
$12K ﹤0.01%
+1
New +$30.5K
ARW icon
1855
Arrow Electronics
ARW
$10.4B
$12K ﹤0.01%
+218
New +$12.4K
BANR icon
1856
Banner Corp
BANR
$2.4B
$12K ﹤0.01%
253
-732
-74% -$36.2K
BBC icon
1857
Virtus Biotech Clinical Trials ETF
BBC
$49.9M
$12K ﹤0.01%
396
-254
-39% -$7.34K
BBY icon
1858
Best Buy
BBY
$17.3B
$12K ﹤0.01%
+394
New +$13K
BLDP
1859
Ballard Power Systems
BLDP
$790M
$12K ﹤0.01%
8,010
-92
-1% -$130
BMY icon
1860
Bristol-Myers Squibb
BMY
$132B
$12K ﹤0.01%
+175
New +$11.6K
BR icon
1861
Broadridge
BR
$19B
$12K ﹤0.01%
220
-4,653
-95% -$261K
CDTX
1862
DELISTED
Cidara Therapeutics
CDTX
$12K ﹤0.01%
36
+22
+157% +$6.61K
CERS icon
1863
Cerus
CERS
$474M
$12K ﹤0.01%
+1,965
New +$10.5K
CEV
1864
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$12K ﹤0.01%
+900
New +$11.8K
CGNX icon
1865
Cognex
CGNX
$11.3B
$12K ﹤0.01%
696
-144
-17% -$2.57K
CHRS icon
1866
Coherus Oncology
CHRS
$196M
$12K ﹤0.01%
531
-164
-24% -$4.22K
CRBP icon
1867
Corbus Pharmaceuticals
CRBP
$190M
$12K ﹤0.01%
255
+250
+5,000% +$12.7K
CRMD icon
1868
CorMedix
CRMD
$584M
$12K ﹤0.01%
1,132
+700
+162% +$8.06K
CSD icon
1869
Invesco S&P Spin-Off ETF
CSD
$228M
$12K ﹤0.01%
+300
New +$12.1K
DCI icon
1870
Donaldson
DCI
$11.4B
$12K ﹤0.01%
430
-1,184
-73% -$34.8K
EBS icon
1871
Emergent Biosolutions
EBS
$248M
$12K ﹤0.01%
300
+212
+241% +$7.39K
EES icon
1872
WisdomTree US SmallCap Earnings Fund
EES
$731M
$12K ﹤0.01%
+456
New +$11.9K
EMIF icon
1873
iShares Emerging Markets Infrastructure ETF
EMIF
$13.1M
$12K ﹤0.01%
454
-628
-58% -$18.1K
ERIC icon
1874
Ericsson
ERIC
$33.3B
$12K ﹤0.01%
1,283
+478
+59% +$4.65K
FBIN icon
1875
Fortune Brands Innovations
FBIN
$6.06B
$12K ﹤0.01%
257
-1,750
-87% -$79.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2015 Portfolio in Review

As of Q4 2015, Tower Research Capital (TRC) held 5,864 positions worth $617M, down 40% from $1.03B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $455M in Q4 2015, closing 1,178 positions and reducing 1,785 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2% of assets, down from 2.2% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Tower Research Capital (TRC) opened a new position in ProShares Short S&P500 worth $5.21M.

  • Tower Research Capital (TRC)'s largest Q4 2015 buy was ProShares Short S&P500: 31,192 shares worth $5.21M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2015, an estimated $17.5M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $203M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q4 2015, selling an estimated $28.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $617M portfolio in Q4 2015.
  • Tower Research Capital (TRC) opened 1,647 new positions and closed 1,178 in Q4 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 40% quarter-over-quarter to $617M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.